Corcept Therapeutics (CORT) Stock Forecast & Price Target

CORT$72.94-0.77 -1.04%
Medical - PharmaceuticalsGrowth Stock
Compare
Market cap$7.98BEnterprise value$8.47BRevenue (TTM)$963.65MMarket position—

Score

66
Bullish
Value
54
Quality
59
Growth
84

Corcept Therapeutics Incorporated price target

CORT
Low$50.00
Average$132.80
High$165.00
Upside vs current price+82.1%

The average target of $132.80 is +82.1% versus the current CORT price of $72.94.

Corcept Therapeutics Incorporated analyst ratings

RatingAnalysts
Strong buy1
Buy3
Hold0
Sell1
Strong sell0
ConsensusBuy

5 analysts cover CORT.

Corcept Therapeutics Incorporated EPS and revenue estimates

CORT shows the next fiscal years with at least three analysts: 2026 EPS $2.07, 2027 EPS $4.17. A thinner year is left off this table.

Fiscal yearEPS estimateRevenue estimate
2026$2.07$1.15B
2027$4.17$1.68B

Is Corcept Therapeutics Incorporated a buy or sell?

Of the 5 analysts covering Corcept Therapeutics Incorporated, 4 rate it a buy (1 strong buy and 3 buy), 0 rate it a hold, and 1 rates it a sell (1 sell and 0 strong sell).

The CORT consensus label is Buy, beside 4 buy-side ratings and 1 sell-side ratings.

The average target of $132.80 implies +82.1% versus the current price of $72.94.

Those 5 ratings on CORT are a headcount, and the label on file is Buy.

Reading the Corcept Therapeutics Incorporated forecast

The CORT target range is wide: $50.00 at the low end, $132.80 in the middle, and $165.00 at the top.

Set next to the $72.94 CORT quote, that average is +82.1%.

Ratings on the Corcept Therapeutics Incorporated cluster: 4 of 5 analysts are on the buy side, 0 are at hold, and 1 is on the sell side, and the published consensus is Buy.

Recent CORT revisions are two-sided: 0 upgrades and 1 downgrades.

The CORT EPS path from 2026 ($2.07) to 2027 ($4.17) is rising.

Only 5 analysts cover CORT, so the average rests on a short list.

Corcept Therapeutics Incorporated forecast questions

What is the CORT price target?

The published range for CORT is $50.00 to $165.00, with an average of $132.80. That average is +82.1% versus the current price of $72.94.

Is Corcept Therapeutics Incorporated a buy or sell?

Of the 5 analysts covering Corcept Therapeutics Incorporated, 4 rate it a buy, 0 rate it a hold, and 1 rates it a sell. The consensus is Buy, and the CORT headcount is 4 buy, 0 hold, and 1 sell.

What is the EPS estimate for Corcept Therapeutics Incorporated?

Analyst EPS estimates for Corcept Therapeutics Incorporated: 2026 $2.07, 2027 $4.17.

What is the revenue estimate for Corcept Therapeutics Incorporated?

Analyst revenue estimates for Corcept Therapeutics Incorporated: 2026 $1.15B, 2027 $1.68B.

How many analysts cover CORT?

5 analysts cover CORT. Their consensus on CORT is Buy, across those 5.

CORT price $72.94 -0.77 -1.04%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener